RU95101728A - Preparation exhibiting immunomodulating properties - Google Patents
Preparation exhibiting immunomodulating propertiesInfo
- Publication number
- RU95101728A RU95101728A RU95101728/14A RU95101728A RU95101728A RU 95101728 A RU95101728 A RU 95101728A RU 95101728/14 A RU95101728/14 A RU 95101728/14A RU 95101728 A RU95101728 A RU 95101728A RU 95101728 A RU95101728 A RU 95101728A
- Authority
- RU
- Russia
- Prior art keywords
- hybrid protein
- buffer system
- salt buffer
- preparation
- protein
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
FIELD: biotechnology, veterinary science, pharmacy. SUBSTANCE: invention proposes preparation exhibiting immunomodulating properties and containing hybrid protein T-FNO-T isolated from microorganism with the inserted recombinant plasmid pThi 325 encoding synthesis of protein, stabilizing additions and salt buffer system at the following ratio of components, wt.-%: hybrid protein 0.0008-0.0015; stabilizing additions 10-20; salt buffer system at pH = 7.0-7.2, and water - the rest. Stabilizing additions: polyglucin, gelatinol, sucrose; salt buffer system - buffered saline solution of sodium chloride. Lyophilized medicinal preparation can be used for nonspecific prophylaxis and treatment of infectious diseases. EFFECT: high purity of preparation, absence of by-side effects. 6 tbl
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU95101728A RU2102988C1 (en) | 1995-02-10 | 1995-02-10 | Preparation showing immunomodulating activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU95101728A RU2102988C1 (en) | 1995-02-10 | 1995-02-10 | Preparation showing immunomodulating activity |
Publications (2)
Publication Number | Publication Date |
---|---|
RU95101728A true RU95101728A (en) | 1997-02-27 |
RU2102988C1 RU2102988C1 (en) | 1998-01-27 |
Family
ID=20164606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95101728A RU2102988C1 (en) | 1995-02-10 | 1995-02-10 | Preparation showing immunomodulating activity |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2102988C1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1476541B1 (en) * | 2002-01-18 | 2008-07-16 | ZymoGenetics, Inc. | Cytokine (zcytor17 ligand) |
-
1995
- 1995-02-10 RU RU95101728A patent/RU2102988C1/en active
Also Published As
Publication number | Publication date |
---|---|
RU2102988C1 (en) | 1998-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5789384A (en) | Pharmaceutical dipeptide compositions and methods of use thereof | |
AR002976A1 (en) | PARENTERAL PHARMACEUTICAL FORMULATIONS OF LONG-TERM EFFECT OF INSULIN; CRYSTALS OF SUCH ANALOGUES APPLICABLE IN SUCH FORMULATIONS AND PROCEDURE OF THE FORMULATIONS MENTIONED | |
KR970706830A (en) | COMPOSITION OF CISPLATIN IN COMBINATION WITH 2, 2'-DITHIO-BIS (ETHANESULFONATE) (DIMESNA) | |
GB2193631A (en) | Stable granulocyte colony stimulating factor composition | |
RU94046251A (en) | Glucagon-like peptide and derivatives of insulinotropine, method of synthesis, pharmaceutical compositions, method of diabetes treatment | |
JPH06507639A (en) | Amino acid sequence homology between selectin and B pertussis toxin - peptides derived therefrom, antibodies thereto, pharmaceutical compositions | |
US6566334B1 (en) | Short amphipathic peptides with activity against bacteria and intracellular pathogens | |
DK175381B1 (en) | Pharmaceutical composition for the treatment of immunodeficiency conditions | |
JPS63146829A (en) | Stable granulocyte colony stimulating factor-containing preparation | |
US4322341A (en) | Peptide, process for preparation thereof and use thereof | |
JPH06507386A (en) | therapeutic peptides | |
ES2223105T3 (en) | PEPTIDE FRAGMENT OF THE ANTI-LPS FACTOR OF LIMULO (LALF) THAT HAS ANTIVIRICAL ACTION. | |
RU95101728A (en) | Preparation exhibiting immunomodulating properties | |
US4349466A (en) | Peptide, process for preparation thereof and use thereof | |
SV1996000001A (en) | NEW LISOZYME DIMER APPLICATIONS | |
KR950005325A (en) | Pharmaceutical composition | |
ES2292244T3 (en) | USE OF LISOZYM C MODIFIED TO PREPARE MEDICINAL COMPOSITIONS TO TREAT CERTAIN SERIOUS DISEASES. | |
Kadurugamuwa et al. | Protein antigens of encapsulated Klebsiella pneumoniae surface exposed after growth in the presence of subinhibitory concentrations of cephalosporins | |
EP0302836B1 (en) | Pharmaceutical compositions for topical use containing miocamycin | |
US5268169A (en) | Treatment method of ovarian cancer using interferon gamma | |
RU2349339C1 (en) | Medicine with immune modifying, antivirus, antibacterial antioxidising, membrane stabilising, cartilage and connective tissue growth stimulating effect | |
JP2766303B2 (en) | Superoxide dismutase modified with glycosaminoglycan and method for producing the same | |
KR100266929B1 (en) | Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof. | |
EP1031351B1 (en) | Leishmaniasis remedy containing glucopyranose derivative as the active ingredient | |
US3773928A (en) | Treatment of virus-induced diseases with orgotein |